PMID- 37812879 OWN - NLM STAT- MEDLINE DCOM- 20231030 LR - 20231031 IS - 2213-2317 (Electronic) IS - 2213-2317 (Linking) VI - 67 DP - 2023 Nov TI - Changes to insulin sensitivity in glucose clearance systems and redox following dietary supplementation with a novel cysteine-rich protein: A pilot randomized controlled trial in humans with type-2 diabetes. PG - 102918 LID - S2213-2317(23)00319-1 [pii] LID - 10.1016/j.redox.2023.102918 [doi] LID - 102918 AB - We recently developed a novel keratin-derived protein (KDP) rich in cysteine, glycine, and arginine, with the potential to alter tissue redox status and insulin sensitivity. The KDP was tested in 35 human adults with type-2 diabetes mellitus (T2DM) in a 14-wk randomised controlled pilot trial comprising three 2x20 g supplemental protein/day arms: KDP-whey (KDPWHE), whey (WHEY), non-protein isocaloric control (CON), with standardised exercise. Outcomes were measured morning fasted and following insulin-stimulation (80 mU/m(2)/min hyperinsulinaemic-isoglycaemic clamp). With KDPWHE supplementation there was good and very-good evidence for moderate-sized increases in insulin-stimulated glucose clearance rate (GCR; 26%; 90% confidence limits, CL 2%, 49%) and skeletal-muscle microvascular blood flow (46%; 16%, 83%), respectively, and good evidence for increased insulin-stimulated sarcoplasmic GLUT4 translocation (18%; 0%, 39%) vs CON. In contrast, WHEY did not effect GCR (-2%; -25%, 21%) and attenuated HbA1c lowering (14%; 5%, 24%) vs CON. KDPWHE effects on basal glutathione in erythrocytes and skeletal muscle were unclear, but in muscle there was very-good evidence for large increases in oxidised peroxiredoxin isoform 2 (oxiPRX2) (19%; 2.2%, 35%) and good evidence for lower GPx1 concentrations (-40%; -4.3%, -63%) vs CON; insulin stimulation, however, attenuated the basal oxiPRX2 response (4%; -16%, 24%), and increased GPx1 (39%; -5%, 101%) and SOD1 (26%; -3%, 60%) protein expression. Effects of KDPWHE on oxiPRX3 and NRF2 content, phosphorylation of capillary eNOS and insulin-signalling proteins upstream of GLUT4 translocation Akt(Ser437) and AS160(Thr642) were inconclusive, but there was good evidence for increased IRS(Ser312) (41%; 3%, 95%), insulin-stimulated NFkappaB-DNA binding (46%; 3.4%, 105%), and basal PAK-1(Thr423)/2(Thr402) phosphorylation (143%; 66%, 257%) vs WHEY. Our findings provide good evidence to suggest that dietary supplementation with a novel edible keratin protein in humans with T2DM may increase glucose clearance and modify skeletal-muscle tissue redox and insulin sensitivity within systems involving peroxiredoxins, antioxidant expression, and glucose uptake. CI - Copyright (c) 2023 The Authors. Published by Elsevier B.V. All rights reserved. FAU - Peeters, W M AU - Peeters WM AD - Metabolic and Microvascular Laboratory, School of Sport, Exercise and Nutrition, Massey University, Wellington, Auckland, New Zealand; School of Biomedical, Nutritional and Sport Science, Newcastle University, United Kingdom. FAU - Gram, M AU - Gram M AD - Metabolic and Microvascular Laboratory, School of Sport, Exercise and Nutrition, Massey University, Wellington, Auckland, New Zealand. FAU - Dias, G J AU - Dias GJ AD - Department of Anatomy, University of Otago, Dunedin, New Zealand. FAU - Vissers, M C M AU - Vissers MCM AD - Centre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. FAU - Hampton, M B AU - Hampton MB AD - Centre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. FAU - Dickerhof, N AU - Dickerhof N AD - Centre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. FAU - Bekhit, A E AU - Bekhit AE AD - Department of Food Sciences, University of Otago, Dunedin, New Zealand. FAU - Black, M J AU - Black MJ AD - Metabolic and Microvascular Laboratory, School of Sport, Exercise and Nutrition, Massey University, Wellington, Auckland, New Zealand. FAU - Oxboll, J AU - Oxboll J AD - Metabolic and Microvascular Laboratory, School of Sport, Exercise and Nutrition, Massey University, Wellington, Auckland, New Zealand. FAU - Bayer, S AU - Bayer S AD - Centre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. FAU - Dickens, M AU - Dickens M AD - School of Health Sciences, Massey University, Wellington, Auckland, New Zealand. FAU - Vitzel, K AU - Vitzel K AD - School of Health Sciences, Massey University, Wellington, Auckland, New Zealand. FAU - Sheard, P W AU - Sheard PW AD - Department of Physiology, University of Otago, Dunedin, New Zealand. FAU - Danielson, K M AU - Danielson KM AD - Department of Anaesthesiology and Surgery, University of Otago, Wellington, New Zealand. FAU - Hodges, L D AU - Hodges LD AD - Metabolic and Microvascular Laboratory, School of Sport, Exercise and Nutrition, Massey University, Wellington, Auckland, New Zealand. FAU - Brond, J C AU - Brond JC AD - Department of Sports Science and Clinical Biomechanics, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. FAU - Bond, J AU - Bond J AD - Metabolic and Microvascular Laboratory, School of Sport, Exercise and Nutrition, Massey University, Wellington, Auckland, New Zealand. FAU - Perry, B G AU - Perry BG AD - School of Health Sciences, Massey University, Wellington, Auckland, New Zealand. FAU - Stoner, L AU - Stoner L AD - Department of Exercise and Sport Science, University of North Carolina, Chapel Hill, USA. FAU - Cornwall, J AU - Cornwall J AD - Centre for Early Learning in Medicine, University of Otago, Dunedin, New Zealand. FAU - Rowlands, D S AU - Rowlands DS AD - Metabolic and Microvascular Laboratory, School of Sport, Exercise and Nutrition, Massey University, Wellington, Auckland, New Zealand. Electronic address: D.S.Rowlands@massey.ac.nz. LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20231005 PL - Netherlands TA - Redox Biol JT - Redox biology JID - 101605639 RN - IY9XDZ35W2 (Glucose) RN - K848JZ4886 (Cysteine) RN - 0 (Insulin) RN - 0 (Protein Isoforms) RN - 68238-35-7 (Keratins) SB - IM MH - Adult MH - Humans MH - Glucose/metabolism MH - *Insulin Resistance MH - Cysteine/metabolism MH - Pilot Projects MH - Insulin/metabolism MH - Muscle, Skeletal/metabolism MH - *Diabetes Mellitus, Type 2/metabolism MH - Protein Isoforms/metabolism MH - Dietary Supplements MH - Oxidation-Reduction MH - Keratins/metabolism/pharmacology PMC - PMC10570009 OTO - NOTNLM OT - Glutathione OT - Keratin OT - Oxidative stress OT - Peroxiredoxin OT - Type-2 diabetes OT - whey COIS- Declaration of competing interest We were unable to get the Elsevier online DOI working, so this document covers declarations. EDAT- 2023/10/10 00:42 MHDA- 2023/10/30 06:47 PMCR- 2023/10/05 CRDT- 2023/10/09 18:21 PHST- 2023/08/22 00:00 [received] PHST- 2023/10/02 00:00 [accepted] PHST- 2023/10/30 06:47 [medline] PHST- 2023/10/10 00:42 [pubmed] PHST- 2023/10/09 18:21 [entrez] PHST- 2023/10/05 00:00 [pmc-release] AID - S2213-2317(23)00319-1 [pii] AID - 102918 [pii] AID - 10.1016/j.redox.2023.102918 [doi] PST - ppublish SO - Redox Biol. 2023 Nov;67:102918. doi: 10.1016/j.redox.2023.102918. Epub 2023 Oct 5.